SIRT3 and cancer: When we investigated the cytotoxic effect of anti-cancer drug (mTOR inhibitor, RSV) in SIRT3 OE cancer cell, it showed the number of cancer cell was significantly decreased in a dose-dependent manner (Fig 3B).